GLP-1 receptor agonists: new kids in the block of renoprotection for people with type 2 diabetes and chronic kidney disease.

Expert Opin Pharmacother

Second Propedeutic Department of Internal Medicine, Hippokration Hospital, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Published: October 2024

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2024.2416584DOI Listing

Publication Analysis

Top Keywords

glp-1 receptor
4
receptor agonists
4
agonists kids
4
kids block
4
block renoprotection
4
renoprotection people
4
people type
4
type diabetes
4
diabetes chronic
4
chronic kidney
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!